TABLE 5.
Adverse effects (AE) to tDCS reported by active or sham tDCS groups.
| Adverse effects | Active tDCS (n = 11) |
Sham tDCS (n = 12) |
p value |
| None or mild (n, %) | 4 (36.6%) | 9 (75%) | 0.10 |
| Moderate or severe (n, %) | 7 (63.6%) | 3 (25%) |
Adverse effects (AE) to tDCS reported by active or sham tDCS groups.
| Adverse effects | Active tDCS (n = 11) |
Sham tDCS (n = 12) |
p value |
| None or mild (n, %) | 4 (36.6%) | 9 (75%) | 0.10 |
| Moderate or severe (n, %) | 7 (63.6%) | 3 (25%) |